2011 - 2020 of 9140 Results
Title
Year
- Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns’ based approach2020RESTRICTEDTitle: Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns’ based approachJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 47Issue #: 12Start Page: 2901End Page: 2910Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-04785-zCitation Count: 40
-
OPENTitle: Validation of the Waterless Empirical Taste Test (WETT®)Journal Name: Behavior Research MethodsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 2Start Page: 864End Page: 873Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3758/s13428-020-01463-8Best OA location URL: https://link.springer.com/content/pdf/10.3758/s13428-020-01463-8.pdfCitation Count: 33
- Structural brain correlates of irritability and aggression in early manifest Huntington’s disease2020RESTRICTEDTitle: Structural brain correlates of irritability and aggression in early manifest Huntington’s diseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 107End Page: 113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-019-00237-xCitation Count: 25
-
OPENTitle: The microgravity enhanced polymer-mediated siRNA gene silence by improving cellular uptakeJournal Name: Biophysics ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 6Start Page: 266End Page: 277Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s41048-020-00121-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s41048-020-00121-y.pdfCitation Count: 8
- β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study2020RESTRICTEDTitle: β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control StudyJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 34Issue #: 7Start Page: 763End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-020-00736-2Citation Count: 16
-
RESTRICTEDTitle: Evaluation of Prescription Practices of Domperidone in Parkinson’s Disease: A Cross Sectional Study Among French NeurologistsJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 34Issue #: 12Start Page: 1267End Page: 1274Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-020-00774-wBest OA location URL: https://hal.sorbonne-universite.fr/hal-03894187Citation Count: 3
- Orthostatic hypotension preceding dementia with Lewy bodies by over 15 years: a clinicopathologic case report2020RESTRICTEDTitle: Orthostatic hypotension preceding dementia with Lewy bodies by over 15 years: a clinicopathologic case reportJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page: 575End Page: 577Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00730-0Citation Count: 2
- Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D2020RESTRICTEDTitle: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&DJournal Name: Research PolicyPublisher: Elsevier BVVol: 49Issue #: 8Start Page: 104032End Page: 104032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032Citation Count: 5
- Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study2019RESTRICTEDTitle: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5Citation Count: 126
- Multiple sclerosis in 2019: predicting progression2019RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1